Hepcidin levels and gastric cancer risk in the EPIC-EurGast Study
Hepcidin is the main regulator of iron homeostasis and dysregulation of proteins involved in iron metabolism has been associated with tumorogenesis. However, to date, no epidemiological study has researched the association between hepcidin levels and gastric cancer risk. To further investigate the r...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Wiley
2017
|
| _version_ | 1797097951671091200 |
|---|---|
| author | Jakszyn, P Fonseca-Nunes, A Lujan-Barroso, L Aranda, N Tous, M Arija, V Cross, A de Mesquita, B Weiderpass, E Kühn, T Kaaks, R Sjöberg, K Ohlsson, B Tumino, R Palli, D Ricceri, F Fasanelli, F Krogh, V Mattiello, A Jenab, M Gunter, M Perez-Cornago, A Khaw, KT Tjønneland, A Olsen, A Overvad, K Trichopoulou, A Peppa, E Vasilopoulou, E Boeing, H Sánchez-Cantalejo, E Huerta, JM Dorronsoro, M Barricarte, A Quirós, JM Peeters, PH Agudo, A |
| author_facet | Jakszyn, P Fonseca-Nunes, A Lujan-Barroso, L Aranda, N Tous, M Arija, V Cross, A de Mesquita, B Weiderpass, E Kühn, T Kaaks, R Sjöberg, K Ohlsson, B Tumino, R Palli, D Ricceri, F Fasanelli, F Krogh, V Mattiello, A Jenab, M Gunter, M Perez-Cornago, A Khaw, KT Tjønneland, A Olsen, A Overvad, K Trichopoulou, A Peppa, E Vasilopoulou, E Boeing, H Sánchez-Cantalejo, E Huerta, JM Dorronsoro, M Barricarte, A Quirós, JM Peeters, PH Agudo, A |
| author_sort | Jakszyn, P |
| collection | OXFORD |
| description | Hepcidin is the main regulator of iron homeostasis and dysregulation of proteins involved in iron metabolism has been associated with tumorogenesis. However, to date, no epidemiological study has researched the association between hepcidin levels and gastric cancer risk. To further investigate the relationship between hepcidin levels and gastric cancer risk, we conducted a nested case-control study (EURGAST) within the multicentric European Prospective Investigation into Cancer and Nutrition (EPIC) study. The study included 456 primary incident gastric adenocarcinoma cases and 900 matched controls that occurred during an average of 11 years of follow-up. We measured serum levels of hepcidin-25, iron, ferritin, transferrin and C-reactive protein. Odds ratios (ORs) and 95% confidence intervals (CIs) for the risk of gastric cancer by hepcidin levels were estimated from multivariable conditional logistic regression models. Mediation effect of the ferritin levels on the hepcidin-gastric cancer pathway was also evaluated. After adjusting for relevant confounders, we observed a statistically significant inverse association between gastric cancer and hepcidin levels (OR 5ng/l = 0.96, 95% CI = 0.93-0.99). No differences were found by tumor localization or histological type. In mediation analysis, we found that the direct effect of hepcidin only represents a non-significant 38% (95% CI: -69%, 91%). In summary, these data suggest that the inverse association of hepcidin levels and gastric cancer risk was mostly accounted by ferritin levels. Further investigation including repeated measures of hepcidin is needed to clarify their role in gastric carcinogenesis. This article is protected by copyright. All rights reserved. |
| first_indexed | 2024-03-07T05:02:40Z |
| format | Journal article |
| id | oxford-uuid:d8d6ada3-9868-4287-aa10-024fa617e924 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T05:02:40Z |
| publishDate | 2017 |
| publisher | Wiley |
| record_format | dspace |
| spelling | oxford-uuid:d8d6ada3-9868-4287-aa10-024fa617e9242022-03-27T08:51:46ZHepcidin levels and gastric cancer risk in the EPIC-EurGast StudyJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:d8d6ada3-9868-4287-aa10-024fa617e924EnglishSymplectic Elements at OxfordWiley2017Jakszyn, PFonseca-Nunes, ALujan-Barroso, LAranda, NTous, MArija, VCross, Ade Mesquita, BWeiderpass, EKühn, TKaaks, RSjöberg, KOhlsson, BTumino, RPalli, DRicceri, FFasanelli, FKrogh, VMattiello, AJenab, MGunter, MPerez-Cornago, AKhaw, KTTjønneland, AOlsen, AOvervad, KTrichopoulou, APeppa, EVasilopoulou, EBoeing, HSánchez-Cantalejo, EHuerta, JMDorronsoro, MBarricarte, AQuirós, JMPeeters, PHAgudo, AHepcidin is the main regulator of iron homeostasis and dysregulation of proteins involved in iron metabolism has been associated with tumorogenesis. However, to date, no epidemiological study has researched the association between hepcidin levels and gastric cancer risk. To further investigate the relationship between hepcidin levels and gastric cancer risk, we conducted a nested case-control study (EURGAST) within the multicentric European Prospective Investigation into Cancer and Nutrition (EPIC) study. The study included 456 primary incident gastric adenocarcinoma cases and 900 matched controls that occurred during an average of 11 years of follow-up. We measured serum levels of hepcidin-25, iron, ferritin, transferrin and C-reactive protein. Odds ratios (ORs) and 95% confidence intervals (CIs) for the risk of gastric cancer by hepcidin levels were estimated from multivariable conditional logistic regression models. Mediation effect of the ferritin levels on the hepcidin-gastric cancer pathway was also evaluated. After adjusting for relevant confounders, we observed a statistically significant inverse association between gastric cancer and hepcidin levels (OR 5ng/l = 0.96, 95% CI = 0.93-0.99). No differences were found by tumor localization or histological type. In mediation analysis, we found that the direct effect of hepcidin only represents a non-significant 38% (95% CI: -69%, 91%). In summary, these data suggest that the inverse association of hepcidin levels and gastric cancer risk was mostly accounted by ferritin levels. Further investigation including repeated measures of hepcidin is needed to clarify their role in gastric carcinogenesis. This article is protected by copyright. All rights reserved. |
| spellingShingle | Jakszyn, P Fonseca-Nunes, A Lujan-Barroso, L Aranda, N Tous, M Arija, V Cross, A de Mesquita, B Weiderpass, E Kühn, T Kaaks, R Sjöberg, K Ohlsson, B Tumino, R Palli, D Ricceri, F Fasanelli, F Krogh, V Mattiello, A Jenab, M Gunter, M Perez-Cornago, A Khaw, KT Tjønneland, A Olsen, A Overvad, K Trichopoulou, A Peppa, E Vasilopoulou, E Boeing, H Sánchez-Cantalejo, E Huerta, JM Dorronsoro, M Barricarte, A Quirós, JM Peeters, PH Agudo, A Hepcidin levels and gastric cancer risk in the EPIC-EurGast Study |
| title | Hepcidin levels and gastric cancer risk in the EPIC-EurGast Study |
| title_full | Hepcidin levels and gastric cancer risk in the EPIC-EurGast Study |
| title_fullStr | Hepcidin levels and gastric cancer risk in the EPIC-EurGast Study |
| title_full_unstemmed | Hepcidin levels and gastric cancer risk in the EPIC-EurGast Study |
| title_short | Hepcidin levels and gastric cancer risk in the EPIC-EurGast Study |
| title_sort | hepcidin levels and gastric cancer risk in the epic eurgast study |
| work_keys_str_mv | AT jakszynp hepcidinlevelsandgastriccancerriskintheepiceurgaststudy AT fonsecanunesa hepcidinlevelsandgastriccancerriskintheepiceurgaststudy AT lujanbarrosol hepcidinlevelsandgastriccancerriskintheepiceurgaststudy AT arandan hepcidinlevelsandgastriccancerriskintheepiceurgaststudy AT tousm hepcidinlevelsandgastriccancerriskintheepiceurgaststudy AT arijav hepcidinlevelsandgastriccancerriskintheepiceurgaststudy AT crossa hepcidinlevelsandgastriccancerriskintheepiceurgaststudy AT demesquitab hepcidinlevelsandgastriccancerriskintheepiceurgaststudy AT weiderpasse hepcidinlevelsandgastriccancerriskintheepiceurgaststudy AT kuhnt hepcidinlevelsandgastriccancerriskintheepiceurgaststudy AT kaaksr hepcidinlevelsandgastriccancerriskintheepiceurgaststudy AT sjobergk hepcidinlevelsandgastriccancerriskintheepiceurgaststudy AT ohlssonb hepcidinlevelsandgastriccancerriskintheepiceurgaststudy AT tuminor hepcidinlevelsandgastriccancerriskintheepiceurgaststudy AT pallid hepcidinlevelsandgastriccancerriskintheepiceurgaststudy AT riccerif hepcidinlevelsandgastriccancerriskintheepiceurgaststudy AT fasanellif hepcidinlevelsandgastriccancerriskintheepiceurgaststudy AT kroghv hepcidinlevelsandgastriccancerriskintheepiceurgaststudy AT mattielloa hepcidinlevelsandgastriccancerriskintheepiceurgaststudy AT jenabm hepcidinlevelsandgastriccancerriskintheepiceurgaststudy AT gunterm hepcidinlevelsandgastriccancerriskintheepiceurgaststudy AT perezcornagoa hepcidinlevelsandgastriccancerriskintheepiceurgaststudy AT khawkt hepcidinlevelsandgastriccancerriskintheepiceurgaststudy AT tjønnelanda hepcidinlevelsandgastriccancerriskintheepiceurgaststudy AT olsena hepcidinlevelsandgastriccancerriskintheepiceurgaststudy AT overvadk hepcidinlevelsandgastriccancerriskintheepiceurgaststudy AT trichopouloua hepcidinlevelsandgastriccancerriskintheepiceurgaststudy AT peppae hepcidinlevelsandgastriccancerriskintheepiceurgaststudy AT vasilopouloue hepcidinlevelsandgastriccancerriskintheepiceurgaststudy AT boeingh hepcidinlevelsandgastriccancerriskintheepiceurgaststudy AT sanchezcantalejoe hepcidinlevelsandgastriccancerriskintheepiceurgaststudy AT huertajm hepcidinlevelsandgastriccancerriskintheepiceurgaststudy AT dorronsorom hepcidinlevelsandgastriccancerriskintheepiceurgaststudy AT barricartea hepcidinlevelsandgastriccancerriskintheepiceurgaststudy AT quirosjm hepcidinlevelsandgastriccancerriskintheepiceurgaststudy AT peetersph hepcidinlevelsandgastriccancerriskintheepiceurgaststudy AT agudoa hepcidinlevelsandgastriccancerriskintheepiceurgaststudy |